• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性非结核分枝杆菌感染患者肺部免疫细胞的特征分析

Characterization of Immune Cells From the Lungs of Patients With Chronic Non-Tuberculous Mycobacteria or Infection.

作者信息

Schenkel Alan R, Mitchell John D, Cool Carlyne D, Bai Xiyuan, Groshong Steve, Koelsch Tilman, Verma Deepshikha, Ordway Diane, Chan Edward D

机构信息

Department of Microbiology, Immunology, & Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Division of Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

Immune Netw. 2022 Apr 11;22(3):e27. doi: 10.4110/in.2022.22.e27. eCollection 2022 Jun.

DOI:10.4110/in.2022.22.e27
PMID:35799709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9250871/
Abstract

Little is known of the lung cellular immunophenotypes in patients with non-tuberculous mycobacterial lung disease (NTM-LD). Flow-cytometric analyses for the major myeloid and lymphoid cell subsets were performed in less- and more-diseased areas of surgically resected lungs from six patients with NTM-LD and two with lung disease (-LD). Lymphocytes, comprised mainly of NK cells, CD4 and CD8 T cells, and B cells, accounted for ~60% of all leukocytes, with greater prevalence of T and B cells in more-diseased areas. In contrast, fewer neutrophils were found with decreased number in more-diseased areas. Compared to NTM-LD, lung tissues from patients with -LD demonstrated relatively lower numbers of T and B lymphocytes but similar numbers of NK cells. While this study demonstrated a large influx of lymphocytes into the lungs of patients with chronic NTM-LD, further analyses of their phenotypes are necessary to determine the significance of these findings.

摘要

关于非结核分枝杆菌肺病(NTM-LD)患者的肺细胞免疫表型,人们所知甚少。对6例NTM-LD患者和2例肺病(-LD)患者手术切除肺组织中病变较轻和较重区域的主要髓系和淋巴细胞亚群进行了流式细胞术分析。淋巴细胞主要由自然杀伤(NK)细胞、CD4和CD8 T细胞以及B细胞组成,占所有白细胞的约60%,在病变较重区域T细胞和B细胞的比例更高。相比之下,中性粒细胞数量较少,且在病变较重区域数量减少。与NTM-LD患者相比,-LD患者的肺组织中T淋巴细胞和B淋巴细胞数量相对较少,但NK细胞数量相似。虽然这项研究表明慢性NTM-LD患者的肺部有大量淋巴细胞浸润,但有必要对其表型进行进一步分析,以确定这些发现的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/04c1ad282740/in-22-e27-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/1740c6ce7266/in-22-e27-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/07fab1c9557c/in-22-e27-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/0e2c381ecd5c/in-22-e27-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/04c1ad282740/in-22-e27-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/1740c6ce7266/in-22-e27-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/07fab1c9557c/in-22-e27-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/0e2c381ecd5c/in-22-e27-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b613/9250871/04c1ad282740/in-22-e27-g004.jpg

相似文献

1
Characterization of Immune Cells From the Lungs of Patients With Chronic Non-Tuberculous Mycobacteria or Infection.慢性非结核分枝杆菌感染患者肺部免疫细胞的特征分析
Immune Netw. 2022 Apr 11;22(3):e27. doi: 10.4110/in.2022.22.e27. eCollection 2022 Jun.
2
Histopathologic Analysis of Surgically Resected Lungs of Patients with Non-tuberculous Mycobacterial Lung Disease: a Retrospective and Hypothesis-generating Study.非结核分枝杆菌肺病患者手术切除肺组织的病理分析:一项回顾性和假说生成研究。
Yale J Biol Med. 2021 Dec 29;94(4):527-535. eCollection 2021 Dec.
3
The Trend of TIM3 Expression on T Cells in Patients With Nontuberculous Mycobacterial Lung Disease: From Immune Cell Dysfunction to Clinical Severity.非结核分枝杆菌肺病患者 T 细胞中 TIM3 表达的趋势:从免疫细胞功能障碍到临床严重程度。
Front Immunol. 2021 Nov 10;12:738056. doi: 10.3389/fimmu.2021.738056. eCollection 2021.
4
Non-Tuberculous Mycobacteria in Respiratory Specimens of Patients with Obstructive Lung Diseases-Colonization or Disease?阻塞性肺疾病患者呼吸道标本中的非结核分枝杆菌——定植还是疾病?
Antibiotics (Basel). 2020 Jul 20;9(7):424. doi: 10.3390/antibiotics9070424.
5
Treatment of Non-Tuberculous Mycobacterial Lung Disease.非结核分枝杆菌肺病的治疗
Curr Treat Options Infect Dis. 2016 Dec;8(4):275-296. doi: 10.1007/s40506-016-0086-4. Epub 2016 Oct 11.
6
Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization.可溶性 T 细胞免疫球蛋白黏蛋白结构域 3 在鉴别非结核分枝杆菌肺病与肺部定植中的作用。
Arch Bronconeumol. 2022 Jul;58(7):547-553. doi: 10.1016/j.arbres.2021.01.035. Epub 2021 Feb 24.
7
Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.髓系精氨酸酶-1 可控制铜绿假单胞菌肺炎中的过度炎症反应并调节 T 细胞应答。
Immunobiology. 2021 Jan;226(1):152034. doi: 10.1016/j.imbio.2020.152034. Epub 2020 Nov 24.
8
The Clinical Significance of Programmed Death-1, Regulatory T Cells and Myeloid Derived Suppressor Cells in Patients with Nontuberculous Mycobacteria-Lung Disease.程序性死亡蛋白-1、调节性T细胞和髓源性抑制细胞在非结核分枝杆菌肺病患者中的临床意义
J Clin Med. 2019 May 23;8(5):736. doi: 10.3390/jcm8050736.
9
[Clinical and Laboratory Characteristics of Disseminated Non-tuberculous Mycobacterial Disease].播散性非结核分枝杆菌病的临床和实验室特征
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Apr 28;41(2):242-247. doi: 10.3881/j.issn.1000-503X.11183.
10
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study.非结核分枝杆菌肺病患者治疗的临床结局真实世界评估:一项十年队列研究。
Respir Med. 2020 Apr;164:105899. doi: 10.1016/j.rmed.2020.105899. Epub 2020 Feb 14.

引用本文的文献

1
P3MA: A Promising Mycobacteriophage Infecting .P3MA:一种有前景的感染……的分枝杆菌噬菌体
Antibiotics (Basel). 2025 Aug 6;14(8):801. doi: 10.3390/antibiotics14080801.
2
Sarcoidosis, and Noncaseating Granulomas: Who Moved My Cheese.结节病与非干酪样肉芽肿:谁动了我的奶酪。
Microorganisms. 2023 Mar 24;11(4):829. doi: 10.3390/microorganisms11040829.
3
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen.用异源 RNA 初免和蛋白加强疫苗方案预防鸟分枝杆菌的免疫原性和保护作用。

本文引用的文献

1
Airway Natural Killer Cells and Bacteria in Health and Disease.气道自然杀伤细胞与健康和疾病中的细菌。
Front Immunol. 2020 Sep 25;11:585048. doi: 10.3389/fimmu.2020.585048. eCollection 2020.
2
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南。
Clin Infect Dis. 2020 Aug 14;71(4):905-913. doi: 10.1093/cid/ciaa1125.
3
Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.
Tuberculosis (Edinb). 2023 Jan;138:102302. doi: 10.1016/j.tube.2022.102302. Epub 2022 Dec 27.
年龄相关 B 细胞出现在患有肉芽肿性肺病的患者中。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):1013-1023. doi: 10.1164/rccm.201911-2151OC.
4
Characteristics of Circulating CD4 T Cell Subsets in Patients with Complex Pulmonary Disease.复杂肺部疾病患者循环CD4 T细胞亚群的特征
J Clin Med. 2020 May 3;9(5):1331. doi: 10.3390/jcm9051331.
5
Improving the Quality and Reproducibility of Flow Cytometry in the Lung. An Official American Thoracic Society Workshop Report.提高肺部流式细胞术的质量和可重复性:美国胸科学会官方研讨会报告
Am J Respir Cell Mol Biol. 2019 Aug;61(2):150-161. doi: 10.1165/rcmb.2019-0191ST.
6
Surgical Treatment of Pulmonary Nontuberculous Mycobacterial Infections.肺部非结核分枝杆菌感染的外科治疗
Thorac Surg Clin. 2019 Feb;29(1):77-83. doi: 10.1016/j.thorsurg.2018.09.011.
7
Impact of Treg on other T cell subsets in progression of fibrosis in experimental lung fibrosis.调节性T细胞对实验性肺纤维化进展中其他T细胞亚群的影响
Tissue Cell. 2018 Aug;53:87-92. doi: 10.1016/j.tice.2018.06.003. Epub 2018 Jun 18.
8
Neutrophil predominance in bronchoalveolar lavage fluid is associated with disease severity and progression of HRCT findings in pulmonary Mycobacterium avium infection.支气管肺泡灌洗液中中性粒细胞占优势与鸟分枝杆菌肺部感染的疾病严重程度及高分辨率CT表现的进展相关。
PLoS One. 2018 Feb 5;13(2):e0190189. doi: 10.1371/journal.pone.0190189. eCollection 2018.
9
The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease.Th1/Th17 平衡决定了小鼠放射性肺损伤中的纤维化反应。
Sci Rep. 2017 Sep 14;7(1):11586. doi: 10.1038/s41598-017-11656-5.
10
Type 2 immunity in tissue repair and fibrosis.组织修复和纤维化中的 2 型免疫。
Nat Rev Immunol. 2018 Jan;18(1):62-76. doi: 10.1038/nri.2017.90. Epub 2017 Aug 30.